These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15914479)

  • 1. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.
    Low RN; Duggan B; Barone RM; Saleh F; Song SY
    Radiology; 2005 Jun; 235(3):918-26. PubMed ID: 15914479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study.
    Low RN; Saleh F; Song SY; Shiftan TA; Barone RM; Lacey CG; Goldfarb PM
    Radiology; 1999 May; 211(2):519-28. PubMed ID: 10228537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer recurrence: value of MR imaging.
    Forstner R; Hricak H; Powell CB; Azizi L; Frankel SB; Stern JL
    Radiology; 1995 Sep; 196(3):715-20. PubMed ID: 7644634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
    Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S
    Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?
    Dresen RC; Beets GL; Rutten HJ; Engelen SM; Lahaye MJ; Vliegen RF; de Bruïne AP; Kessels AG; Lammering G; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):71-80. PubMed ID: 19403847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
    Kim BS; Hayashi PH; Kim SH; Angthong W; Srirattanapong S; Woosley JT; Semelka RC
    Radiology; 2013 Jul; 268(1):109-19. PubMed ID: 23392426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer.
    Kierkegaard O; Mogensen O; Mogensen B; Jakobsen A
    Gynecol Oncol; 1995 Nov; 59(2):251-4. PubMed ID: 7590482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging.
    Dresen RC; Kusters M; Daniels-Gooszen AW; Cappendijk VC; Nieuwenhuijzen GA; Kessels AG; de Bruïne AP; Beets GL; Rutten HJ; Beets-Tan RG
    Radiology; 2010 Jul; 256(1):143-50. PubMed ID: 20574091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
    Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M
    Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
    de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC
    Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.
    Del Grande F; Subhawong T; Weber K; Aro M; Mugera C; Fayad LM
    Radiology; 2014 May; 271(2):499-511. PubMed ID: 24495264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
    Frei KA; Kinkel K; Bonel HM; Lu Y; Esserman LJ; Hylton NM
    AJR Am J Roentgenol; 2000 Dec; 175(6):1577-84. PubMed ID: 11090379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
    Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
    Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.